- EmVision Medical Devices (EMV) has welcomed new members to its Clinical Advisory Board in an ex-officio capacity
- Professors Geoffrey Donnan and Stephan Davis, eminent neurologists and leaders in the field of stroke care, will join the EMVision’s Clinical Advisory Board as Co-Chairs of the Australian Stroke Alliance
- Meanwhile, the professors will also be joined by stroke neurologist and Mobile Stroke Unit (MSU) expert, Dr Angela Dos Santos, Australia’s first Aboriginal neurologist with subspecialty training in stroke
- EmVision says the three new recruits to the board are incredibly strong additions to its clinical advisors
- EmVision Medical Devices is up 1.07 per cent, trading at $1.89 at 11:20 am AEDT
EmVision Medical Devices (EMV) has welcomed new members to its Clinical Advisory Board.
Professors Geoffrey Donnan and Stephan Davis, eminent neurologists and leaders in the field of stroke care, will join the EMVision’s Clinical Advisory Board in an ex-officio capacity as Co-Chairs of the Australian Stroke Alliance.
Professor Geoff Donnan is a former president of the World Stroke Organization and was chair of the World Congress of Neurology. He currently holds the role of co-chair of the Australian Stroke Alliance and has provided the rationale for acute stroke therapies, while being involved in several international initiatives.
“Working with EMVision on the clinical translation of their lightweight imaging device represents a once in a generation opportunity to revolutionise the delivery of acute stroke care to all Australians,” said Professor Donnan.
“The concept of bringing imaging to the patient will dramatically reduce times to administer life saving interventions such as thrombolysis and thrombectomy.”
Professor Davis is the Professor of Translational Neuroscience at the University of Melbourne, Director of the Melbourne Brain Centre at the Royal Melbourne Hospital, and a former president of the World Stroke Organisation, as well as being co-chair of the Australian Stroke Alliance.
He and Professor Donnan established and lead the Melbourne Mobile Stroke Unit program, marking a first in Australia.
Meanwhile, the professors will also be joined by stroke neurologist and Mobile Stroke Unit (MSU) expert, Dr Angela Dos Santos. Dr Angela Dos Santos is Australia’s first Aboriginal neurologist with subspecialty training in stroke.
“With so many Australians and in particular a large proportion of Aboriginal and Torres Strait Islander patients living vast distances from stroke imaging, this company holds promise in being able to reduce stroke care inequity,” said Dr Dos Santos.
EmVision CEO, Dr Ron Weinberger, said the three new recruits to the board are incredibly strong additions to its clinical advisors.
EmVision Medical Devices was up 1.07 per cent, trading at $1.89 at 11:20 am AEDT.